对外部光束辐射与肝细胞癌跨动脉化学栓塞的随机对照试验的元分析

Ryan A Kuehnle1, Leila T Tchelebi2, Ethan B Ludmir3

  • 1Long School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.

Cancer
|January 31, 2025
PubMed
概括

与跨动脉化学栓塞 (TACE) 相比,外部束辐射疗法 (EBRT) 改善了肝细胞癌 (HCC) 的局部控制和无进展生存率. 然而,这两种治疗方法的生存益处并没有显著不同.

相关概念视频

Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
96
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K